Type 2 Diabetes Mellitus

CLINICAL_TRIALS research · 2025-02-12

Clinical Trial Update: To Understand the Self-care Ability of Farmers and Fishermen With CMDs (Hypertension, Heart Disease, Hyperlipidemia, Type 2 Diabetes), Whether They Are Aware of CMDs, Their Treatment Status, Treatment Effectiveness, and Their Ability to Describe Known and Practice the Self-care Content of CMDs. [NA]

A clinical trial sponsored by Chang Gung Memorial Hospital is recruiting to assess self-care ability, disease awareness, treatment status, a…

EMA approval · 2025-02-11

EMA Authorised: Repaglinide Teva (repaglinide) — Teva Pharma B.V.

The EMA has authorised Repaglinide Teva (repaglinide) for the treatment of type 2 diabetes mellitus, with Teva Pharma B.V. as the marketing …

CLINICAL_TRIALS research · 2025-02-11

Clinical Trial Update: Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD [Phase 3]

Phase 3 clinical trial investigating dapagliflozin's effects on inflammatory markers, erythropoiesis, and iron metabolism in people with typ…

CLINICAL_TRIALS trial_result · 2025-02-11

Clinical Trial Update: Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood [NA]

Completed clinical trial evaluating whether omega-3 fatty acids can reduce diabetes risk in subjects with a high number of particles carryin…

CLINICAL_TRIALS research · 2025-02-11

Clinical Trial Update: The Effect of Share Care Model in the Improvement of Diabetes Management

This clinical trial evaluates the Share Care Model for improving diabetes management in adults with Type 2 diabetes. The study is currently …

CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients [Phase 2]

Phase 2 trial of GLY-200 in adults with Type 2 diabetes mellitus to evaluate safety, tolerability, and pharmacodynamic effects; the study ha…

CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes [Phase 4]

A Phase 4 safety study evaluating weekly semaglutide in Chilean adults with Type 2 diabetes has completed, with results posted on 2025-02-10…

CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: Effects of a Health Intervention on Fear of Hypoglycemia : a Pilot Study [NA]

A completed pilot clinical trial from Yangzhou University evaluated whether a health intervention reduces fear of hypoglycemia in people wit…

CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG) [NA]

A completed clinical trial compared real-time continuous glucose monitoring to standard care for preventing hypoglycemia in insulin-treated …

CLINICAL_TRIALS research · 2025-02-10

Clinical Trial Update: Effect of a Postbiotic Intake on Glucose Control and Microbiota Composition of Type 2 Diabetic Subjects: a Randomized Controlled Trial. [NA]

This clinical trial update describes an ongoing randomized controlled trial evaluating whether a postbiotic intake improves glucose control …

CLINICAL_TRIALS research · 2025-02-10

Clinical Trial Update: Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation

The trial is recruiting patients with Type 2 diabetes who are on the transplantation list or who have already undergone orthotopic liver tra…

CLINICAL_TRIALS trial_result · 2025-02-07

Clinical Trial Update: INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II Diabetes [NA]

A completed pilot trial (INTEGRATE-D) evaluating integration of medical and psychosocial care for people with Type 2 diabetes, with results …

CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: Efficacy of Lactobacillus Paracasei LC19 on Type 2 Diabetes [NA]

A clinical trial is recruiting to evaluate the efficacy of the probiotic Lactobacillus Paracasei LC19 in Type 2 diabetes mellitus.

CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise [Phase 3]

Phase 3 study evaluating BGM0504 in poorly controlled Type 2 Diabetes Mellitus patients managed with diet and exercise is currently recruiti…

CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: The Medically Reproducing Bariatric Surgery (MRB) II Study [Phase 2, Phase 3]

This document provides a status update on the Medically Reproducing Bariatric Surgery (MRB) II trial. It notes Phase 2 and Phase 3 activity …

CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: A Study of BGM0504 in Participants with Type 2 Diabetes [Phase 3]

This clinical trial update notes that BrightGene's BGM0504 is in Phase 3 testing for Type 2 diabetes mellitus and is currently recruiting.

CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects [Phase 2]

Results from a Phase 2 trial evaluating the safety and efficacy of an oral insulin formulation in Type 2 diabetes mellitus patients treated …

CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

An ongoing Phase 1/2 study evaluating safety, tolerability and preliminary efficacy of sublingual liraglutide in adults with type 2 diabetes…